Evaluation of magnesium gel infused bone graft in bone defects caused by periodontal disease.

Evaluation of magnesium hexaethyl cellulose gel infused hydroxyapatite with collagen bone graft in the treatment of intrabony defects. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085398

Enrollment

Registered

2025-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K14- Diseases of oral cavity and salivary glands

Interventions

Intervention1: Hydroxyapatite with collagen graft: hydroxyapatite with collagen bone graft will be placed in the intrabony defect. Intervention2: Magnesium gel infused hydroxyapatite with collagen bon

Eligibility

Inclusion criteria

Inclusion criteria: Age group 18-65 years. Patients with good oral hygiene. Probing pocket depth of greater than or equal to 5mm. Intrabony defect depth of greater than or equal to 2mm.

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA: Chronic smokers. Patients with hypertension, diabetes, and other systemic disorders. Patients who are unwilling to participate in the study. Pregnant and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Assessment of intra bony defect fill, bone height and bone width with CBCT analysis.Timepoint: Before the procedure, three months and six months after the procedure.	—

Secondary

Measure	Time frame
Assessment of probing pocket depth and clinical attachment levels.Timepoint: Before the procedure, three months and six months after the procedure.	—

Countries

India

Contacts

Public ContactDr P Raja Babu

Kamineni Institute of dental sciences

drprajababu@gmail.com8639967016

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026